Spots Global Cancer Trial Database for pep005
Every month we try and update this database with for pep005 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Multicenter Study to Evaluate the Safety and Efficacy of PEP005 Topical Gel When Used to Treat Actinic Keratoses on the Head (Face or Scalp) | NCT00700063 | Actinic Keratos... | PEP005 Topical ... PEP005 Topical ... PEP005 Topical ... Vehicle gel PEP005 Topical ... PEP005 Topical ... PEP005 Topical ... Vehicle gel | 18 Years - | Peplin | |
| A Multi-Center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp) | NCT00915551 | Actinic Keratos... | PEP005 (Ingenol... Vehicle Gel | 18 Years - | Peplin | |
| Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Actinic Keratoses | NCT00107965 | Actinic Keratos... | PEP005 PEP005 PEP005 PEP005 PEP005 PEP005 PEP005 PEP005 | 18 Years - | Peplin | |
| A Long Term Follow up Study of Patients Who Have Completed the PEP005-016 or PEP005-025 Studies | NCT00953732 | Actinic Keratos... | Lesion count | 18 Years - | Peplin | |
| Pharmacokinetic Study to Evaluate the Extent of Systemic Absorption of PEP005 | NCT00544258 | Actinic Keratos... | PEP005 | 18 Years - | Peplin | |
| A Multi-center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp) | NCT00916006 | Actinic Keratos... | PEP005 Gel Vehicle gel | 18 Years - | Peplin | |
| PEP005 Gel - Evaluation of the Safety and Efficacy of Ingenol Mebutate Gel on a Superficial Basal Cell Carcinoma on the Trunk or Extremities | NCT01325688 | Superficial Bas... | PEP005 (ingenol... Aluminium disk OpSite(TM) disk | 18 Years - | Peplin | |
| A Study to Evaluate the Photoirritation Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers | NCT00850811 | Actinic Keratos... | PEP005 (ingenol... | 18 Years - 65 Years | Peplin | |
| A Study to Evaluate the Photoallergic Potential of PEP005 (Ingenol Mebutate) Gel, 0.01% in Healthy Volunteers | NCT00850681 | Actinic Keratos... | PEP005 (ingenol... | 18 Years - 65 Years | Peplin | |
| Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses | NCT00375739 | Actinic Keratos... | PEP005 | 18 Years - | Peplin | |
| A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations | NCT00742391 | Actinic Keratos... | PEP005 (ingenol... Vehicle gel | 18 Years - | Peplin | |
| Safety and Toleration of PEP005 Topical Gel When Applied to a Treatment Area of up to 100cm2 | NCT00659893 | Actinic Keratos... | PEP005 Topical ... | 18 Years - | Peplin | |
| Study to Evaluate the Safety and Efficacy of PEP005(Ingenol Mebutate) Gel, 0.05%, in Patients With Seborrhoeic Keratosis | NCT01214564 | Seborrheic Kera... | PEP005 (ingenol... | 18 Years - | Peplin | |
| A Multi-center Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on Non-head Locations (Trunk and Extremities) | NCT00917306 | Actinic Keratos... | PEP005 Gel | 18 Years - | Peplin | |
| Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Nodular Basal Cell Carcinoma | NCT00108121 | Basal Cell Carc... | PEP005 | 18 Years - | Peplin | |
| A Long Term Follow up Study of Patients Who Have Completed the PEP005-020 Study | NCT00952783 | Actinic Keratos... | Lesion count | 18 Years - | Peplin | |
| Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Cutaneous Squamous Cell Carcinoma In Situ | NCT00329121 | Carcinoma, Squa... | PEP005 | 18 Years - | Peplin | |
| A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations | NCT00942604 | Actinic Keratos... | PEP005 (ingenol... Vehicle gel | 18 Years - | Peplin | |
| Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel | NCT00239135 | Keratosis | PEP005 | 18 Years - | Peplin | |
| Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Superficial Basal Cell Carcinoma | NCT00108134 | Basal Cell Carc... | PEP005 | 18 Years - | Peplin | |
| A Long Term Follow up Study of Patients Who Have Complete Clearance of Their Actinic Keratosis (AK) Lesions at the Day 57 Visit in the PEP005-028 Study | NCT00989313 | Actinic Keratos... | Lesion count | 18 Years - | Peplin | |
| A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations | NCT00942604 | Actinic Keratos... | PEP005 (ingenol... Vehicle gel | 18 Years - | Peplin | |
| Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses | NCT00375739 | Actinic Keratos... | PEP005 | 18 Years - | Peplin | |
| A Multi-center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp) | NCT00916006 | Actinic Keratos... | PEP005 Gel Vehicle gel | 18 Years - | Peplin | |
| The Purpose of This Study is to Determine Whether Topical Application of PEP005 is Safe for the Treatment of Common Wart(s) | NCT00546611 | Warts | PEP005 | 18 Years - | Peplin | |
| Pharmacokinetic Study to Evaluate the Extent of Systemic Absorption of PEP005 | NCT00544258 | Actinic Keratos... | PEP005 | 18 Years - | Peplin | |
| To Determine the Maximum Tolerated Dose Level (MTD) of PEP005 Topical Gel in Patients With sBCC | NCT00432185 | Superficial Bas... | PEP005 | 18 Years - | Peplin | |
| A Multi-center Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on Non-head Locations (Trunk and Extremities) | NCT00917306 | Actinic Keratos... | PEP005 Gel | 18 Years - | Peplin | |
| Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Cutaneous Squamous Cell Carcinoma In Situ | NCT00329121 | Carcinoma, Squa... | PEP005 | 18 Years - | Peplin | |
| Safety and Toleration of PEP005 Topical Gel When Applied to a Treatment Area of up to 100cm2 | NCT00659893 | Actinic Keratos... | PEP005 Topical ... | 18 Years - | Peplin |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
